WallStreetZenWallStreetZen

NASDAQ: TENX
Tenax Therapeutics Inc Stock

$5.01+0.42 (+9.15%)
Updated Mar 1, 2024
TENX Price
$5.01
Fair Value Price
$0.89
Market Cap
$1.49M
52 Week Low
$3.77
52 Week High
$64.40
P/E
-0.05x
P/B
0.13x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$7.03M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.05
Operating Cash Flow
-$7M
Beta
0.68
Next Earnings
Mar 28, 2024
Ex-Dividend
N/A
Next Dividend
N/A

TENX Overview

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TENX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TENX ($5.01) is overvalued by 460.21% relative to our estimate of its Fair Value price of $0.89 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TENX ($5.01) is not significantly undervalued (460.21%) relative to our estimate of its Fair Value price of $0.89 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TENX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TENX due diligence checks available for Premium users.

Be the first to know about important TENX news, forecast changes, insider trades & much more!

TENX News

Valuation

TENX fair value

Fair Value of TENX stock based on Discounted Cash Flow (DCF)
Price
$5.01
Fair Value
$0.89
Overvalued by
460.21%
TENX ($5.01) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TENX ($5.01) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TENX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TENX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.05x
Industry
15.19x
Market
36.17x

TENX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.13x
Industry
6.18x
TENX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TENX's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.0M
Profit Margin
0%
TENX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$11.9M
Liabilities
$602.2k
Debt to equity
0.05
TENX's short-term assets ($11.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TENX's short-term assets ($11.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TENX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TENX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.1M
Investing
$0.0
Financing
-$171.3k
TENX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TENX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TENX$1.49M+9.15%-0.05x0.13x
PXMD$1.49M+3.17%-0.03x-2.78x
ADTX$1.51M-2.29%-0.26x-0.36x
DRMA$1.45M-1.09%-0.08x0.23x
AMPE$1.36M+5.81%-0.14x0.25x

Tenax Therapeutics Stock FAQ

What is Tenax Therapeutics's quote symbol?

(NASDAQ: TENX) Tenax Therapeutics trades on the NASDAQ under the ticker symbol TENX. Tenax Therapeutics stock quotes can also be displayed as NASDAQ: TENX.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.

What is the 52 week high and low for Tenax Therapeutics (NASDAQ: TENX)?

(NASDAQ: TENX) Tenax Therapeutics's 52-week high was $64.40, and its 52-week low was $3.77. It is currently -92.22% from its 52-week high and 32.89% from its 52-week low.

How much is Tenax Therapeutics stock worth today?

(NASDAQ: TENX) Tenax Therapeutics currently has 298,280 outstanding shares. With Tenax Therapeutics stock trading at $5.01 per share, the total value of Tenax Therapeutics stock (market capitalization) is $1.49M.

Tenax Therapeutics stock was originally listed at a price of $1,870,128.00 in Dec 31, 1997. If you had invested in Tenax Therapeutics stock at $1,870,128.00, your return over the last 26 years would have been -100%, for an annualized return of -38.95% (not including any dividends or dividend reinvestments).

How much is Tenax Therapeutics's stock price per share?

(NASDAQ: TENX) Tenax Therapeutics stock price per share is $5.01 today (as of Mar 1, 2024).

What is Tenax Therapeutics's Market Cap?

(NASDAQ: TENX) Tenax Therapeutics's market cap is $1.49M, as of Mar 2, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Tenax Therapeutics's market cap is calculated by multiplying TENX's current stock price of $5.01 by TENX's total outstanding shares of 298,280.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.